Sequent Scientific Ltd.
NSE: SEQUENT | BSE: 512529
₹263.70
₹11.70
(4.64%)
As on 03-Aug-2026IST
Market cap
₹11,580 Cr
Revenue (TTM)
₹3,420 Cr
P/E Ratio
65.3
P/B Ratio
4.3
Div. Yield
0 %
Quality Score
3/10
Growth Score
6/10
Valuation Score
4/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹225 Cr
-
ROE
9.1 %
-
ROCE
13.1 %
-
Industry P/E
38.68
-
EV/EBITDA
16.9
-
Debt to Equity
0.2
-
Book Value
₹61.9
-
EPS
₹4.1
-
Face value
2
-
Shares outstanding
438,876,813
10 Years Aggregate
CFO
₹1,129.87 Cr
EBITDA
₹1,850.40 Cr
Net Profit
₹373.29 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sequent Scientific
| 26.5 | -9.8 | 29.4 | 56.4 | 42.9 | -1.8 | 10.2 |
|
BSE Healthcare
| 16.9 | 2.7 | 13.8 | 14.7 | 22.7 | 14.1 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Sequent Scientific
| 12.9 | 52.7 | 29.9 | -45.6 | -5.3 | 139.1 | 4.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sequent Scientific
|
263.7 | 11,579.8 | 3,420.3 | 224.7 | 12.0 | 9.1 | 65.3 | 4.3 |
| 3,116.4 | 25,542.6 | 1,461.8 | 387.4 | 34.5 | 25.2 | 66.1 | 14.8 | |
| 1,969.7 | 37,298.7 | 9,203.5 | 941.3 | 15.4 | 19.6 | 40.4 | 7.5 | |
| 2,442.4 | 2,077.2 | 325.7 | 129.6 | 19.9 | 14.6 | 15.3 | 4.6 | |
| 2,408.9 | 38,730.8 | 4,147.8 | 709.5 | 22.3 | 19.1 | 54.6 | 9.3 | |
| 19,675.0 | 25,160.2 | 2,023.0 | 364.0 | 23.9 | 21.4 | 69.1 | 13.4 | |
| 3,292.8 | 2,026.8 | 501.0 | 48.1 | 10.4 | 15.7 | 42.1 | 6.2 | |
| 4,914.6 | 22,487.1 | 2,569.8 | 735.2 | 34.4 | 19.2 | 30.6 | 5.1 | |
| 199.3 | 26,493.8 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.3 | |
| 2,028.4 | 32,938.0 | 3,373.0 | 199.0 | 12.6 | 4.3 | 154.6 | 6.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Sequent Scientific
Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics,... and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments. Read more
-
Incorporated
1985
-
Chairman
Kamal Sharma
-
Managing Director
Haribabu Bodepudi
-
Group
Sequent
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Sequent Scientific Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsIntimation Under Regulation 30 Of SEBI LODR
21-Jul-2026Notice Of 41St Annual General Meeting
17-Jul-2026No News & Announcements are available.
FAQs for Sequent Scientific
What is the current share price of Sequent Scientific Ltd Today?
The share price of Sequent Scientific Ltd is ₹263.70 (NSE) and ₹263.85 (BSE) as of 03-Aug-2026 IST. Sequent Scientific Ltd has given a return of 42.91% in the last 3 years.
What is the current PB & PE ratio of Sequent Scientific Ltd?
The P/E ratio of Sequent Scientific Ltd is 65.32 times as on 03-Aug-2026, a 69 premium to its peers’ median range of 38.68 times.
The P/B ratio of Sequent Scientific Ltd is 4.26 times as on 03-Aug-2026, a 21 discount to its peers’ median range of 5.41 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
45.14
|
2.96
|
|
2025
|
141.01
|
1.45
|
|
2024
|
0.00
|
4.96
|
|
2023
|
0.00
|
2.82
|
|
2022
|
81.14
|
5.15
|
What is the 52 Week High and Low of Sequent Scientific Ltd?
The 52-week high and low of Sequent Scientific Ltd are Rs 298.00 and Rs 166.00 as of 04-Aug-2026.
What is the market cap of Sequent Scientific Ltd?
Sequent Scientific Ltd has a market capitalisation of ₹ 11,580 Cr as on 03-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sequent Scientific Ltd?
Before investing in Sequent Scientific Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.